ANEB - צמיחת מכירות משנה לשנה ב-12 החודשים האחרונים anebulo.com

Anebulo Pharmaceuticals (ANEB) is implementing energy saving and emission filtration in its laboratories. The rolling annual sales volume indicator confirms the trend, where the value of 0.00 corresponds to the current metric. Financial stability relies on existing cash due to a lack of revenue. Prospects are based on the development of the unique orphan-designated drug nelanebestat for the treatment of hyperemesis gravidarum and addictions.
Anebulo Pharmaceuticals, Inc. - פילוחים אנליטיים ומדדי מפתח (ANEB)

The long-term reliability of an issuer is determined by the business's capacity for systemic scaling. This indicator analyzes revenue dynamics over a rolling year, identifying the actual pace of development or hidden asset degradation. The sales trend relative to the same period last year over a 12-month window allows market noise to be separated from fundamental shifts. For Anebulo Pharmaceuticals (ANEB), this metric reflects the efficiency of raising funds for clinical development. Growth in this indicator confirms the inflow of investments into the creation of antidotes.